Reports Strong Q1 FY27 with 13% Revenue Growth
Eris Lifesciences Limited · ERIS · NSE ·
📈 **Revenue Growth:** Total Revenue from Operations grew by 12.97% YoY to ₹873.25 Crores for the quarter ended June 30, 2026. 💰 **Profitability:** Net Profit After Tax (PAT) increased by 14.56% YoY to ₹143.32 Crores. 📊 **Earnings Per Share (EPS):** Basic EPS saw a significant…